Seltjarnarnes, Iceland

Fridrik Runar Gardarsson

This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignee: Epiendo Pharmaceuticals Ehf. Active years: 2020-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Fridrik Runar Gardarsson. Retrieved from https://idiyas.com/inventor/fridrik-runar-gardarsson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 1


Location History:

  • Reykjavik, IS (2020)
  • Seltjarnarnes, IS (2022 - 2024)

Company Filing History:


Years Active: 2020-2024

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Fridrik Runar Gardarsson

Introduction

Fridrik Runar Gardarsson is a notable inventor based in Seltjarnarnes, Iceland. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on Azithromycin derivatives.

Latest Patents

Fridrik Runar Gardarsson holds three patents, with his latest inventions focusing on Azithromycin derivatives that enhance epithelial barrier properties. These novel compounds have been identified to possess low antimicrobial activity but exhibit significant potential in enhancing epithelial barrier function. The inventions provide valuable applications as medicaments, particularly in treating or preventing diseases related to defects in epithelial cells or conditions that benefit from improved epithelial barrier function, such as respiratory tract diseases.

Career Highlights

Fridrik Runar Gardarsson is associated with Epiendo Pharmaceuticals Ehf, where he continues to develop innovative solutions in the pharmaceutical industry. His work has garnered attention for its potential impact on medical treatments and patient care.

Collaborations

Fridrik collaborates with esteemed colleagues, including Fredrik Lehmann and Peter Teodorovic, contributing to a dynamic research environment that fosters innovation.

Conclusion

Fridrik Runar Gardarsson's contributions to the field of pharmaceuticals through his innovative patents highlight his commitment to enhancing medical treatments. His work continues to pave the way for advancements in epithelial barrier enhancement therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…